Article Information
History
- August 20, 2024.
Article Versions
- You are currently viewing Version 1 of this article (August 20, 2024 - 10:19).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Changjun Wang1,#,
- Yan Lin1,#,
- Ying Xu1,
- Feng Mao1,
- Jinghong Guan1,
- Xuejing Wang1,
- Yanna Zhang1,
- Xiaohui Zhang1,
- Songjie Shen1,
- Ying Zhong1,
- Bo Pan1,
- Li Peng1,
- Xin Huang1,
- Xi Cao1,
- Ru Yao1,
- Xintong Zhou1,
- Zecheng He1,
- Yuhan Liu1,
- Jie Lang2,
- Chenggang Li3,
- Yidong Zhou1,* and
- Qiang Sun1,*
- 1Department of Breast Surgery, Peking Union Medical College Hospital, Beijing, China
- 2Department of Breast Surgery, Beijing Longfu Hospital, Beijing, China
- 3State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China
- ↵*Corresponding authors: Prof. Yidong Zhou, Department of Breast Surgery, Peking Union Medical College Hospital, No. 41, DaMuCang Lane, XiCheng District, Beijing 100041, China. Email: zhouyd{at}pumch.cn; Prof. Qiang Sun, Department of Breast Surgery, Peking Union Medical College Hospital, No. 41, DaMuCang Lane, XiCheng District, Beijing 100041, China. Email: sunqiangpumch{at}sina.com
↵# These authors contributed equally to this work.
Posted August 20, 2024.
Different treatment durations of loperamide in preventing pyrotinib-induced diarrhea: A randomized, parallel-group sub-study of the phase II PHAEDRA trial
